Skip to content

RCT of the Naturopathic Anti-Inflammatory Diet

Randomized Clinical Trial of the Naturopathic Anti-Inflammatory Diet

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00334919
Enrollment
30
Registered
2006-06-08
Start date
2006-05-31
Completion date
2007-12-31
Last updated
2010-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Prediabetes

Keywords

Diabetes, Pre-Diabetes, Anti-Inflammatory Diet, Diet Study, Inflammation, Diabetic Diet

Brief summary

The purpose of this study is to determine if the naturopathic Anti-Inflammatory Diet results in reduced inflammation and a better response by the immune system when compared to a standard diabetic diet based on the current American Diabetes Association guidelines.

Detailed description

This study will test the effects of two different diets on the immune system and inflammation in diabetes and pre-diabetes. These diets are the Anti-Inflammatory Diet (AI Diet) used by many naturopathic doctors and a standard diabetic diet based on the American Diabetes Association recommendations (ADA Diet). The AI diet excludes wheat, dairy products, eggs, red meat, caffeine, alcohol, peanuts and certain fruits and vegetables. The ADA diet includes most foods but controls the amount of each of the food groups. Naturopathic physicians often use healthful diets to treat diseases but many of these diets have not been compared to usual medical diet treatments. We will be looking at blood markers that show how the immune system responds to the different diets. We are expecting that the AI diet will result in less inflammation and a better response by the immune system than the ADA diet. We will also be looking at levels of blood lipids and glucose to see any effects on these risk factors.

Interventions

BEHAVIORALDiet (Anti-Inflammatory or standard diabetic diet)

6 weeks standard ADA diet, then randomized to either ADA or antiinflammatory (AI) diet for 6 weeks

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
National University of Natural Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* BMI: 25-45 kg/m2 * Age 18-75 yrs * Diagnosed with type 2 diabetes or pre-diabetes * At risk for type 2 diabetes. Must meet 2 of the following 3 criteria: BMI 30-45 kg/m2, age 50 or older, and/or family history of type 2 diabetes * Fasting blood glucose of 100-200 mg/dl * Provide informed consent

Exclusion criteria

* Current major debilitating mental or physical illness that would interfere with participation (as determined by the participant's medical history) * Taking diabetic medication other than sulfonylurea * Taking Gymnema silvestra (a naturopathic diabetes treatment) * Taking medications that have anti-inflammatory affects (lipid lowering agents, NSAIDS, COX 2 inhibitors, aspirin, HRT, oral contraceptives, testosterone, seizure medications) * Taking weight loss medications * Severe renal, hepatic, or heart disease * Triglycerides \>500 mg/dL * Bulimia * Pregnancy or lactation * Current excessive use of alcohol * Current/recent chronic use of recreational drugs * Smoker * More than 4 hours/week of aerobic exercise * Have gained or lost more than 15 pounds during previous 6 months * Planning on moving out of the area in the next 4 months * Is a participant in another medical research study * Is following a weight loss diet * Is unwilling to accept random assignment of the experimental diets * Food preferences and/or allergies that will interfere with consumption of experimental diet

Design outcomes

Primary

MeasureTime frame
Cytokines13 weeks

Secondary

MeasureTime frame
Glucose113 weeks
Weight13 weeks
Lipids13 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026